Quick Answer
Journey Medical Corp reported Total Assets of $94.59 million for the year ending 2025.
- Journey Medical Corp showed an increase of +17.9% in Total Assets from 2024 to 2025.
- This data is from Journey Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $89.06 million | Q1 2022: $120.90 million | Q2 2022: $113.50 million | Q3 2022: $108.15 million | Q1 2023: $95.85 million | Q2 2023: $69.75 million | Q3 2023: $65.92 million | Q1 2024: $66.57 million | Q2 2024: $65.19 million | Q3 2024: $64.04 million | Q1 2025: $84.96 million | Q2 2025: $81.16 million | Q3 2025: $85.19 million.
- Over the full 6 years of available data (2020 to 2025), Journey Medical Corp's Total Assets has grown by 82.2%.
- Historical annual values: Fiscal year 2025: $94.59 million | Fiscal year 2024: $80.24 million | Fiscal year 2023: $76.85 million | Fiscal year 2022: $105.16 million | Fiscal year 2021: $97.28 million | Fiscal year 2020: $51.91 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: